Deubiquitinating enzyme CYLD negatively regulates the ubiquitin-dependent kinase Tak1 and prevents abnormal T cell responses
Year: 2007
Type: article
Abstract: The deubiquitinating enzyme CYLD has recently been implicated in the regulation of signal transduction, but its physiological function and mechanism of action are still elusive. In this study, we show that CYLD plays a pivotal role in regulating T cell activation and homeostasis. T cells derived from Cyld knockout mice display a hyperresponsive phenotype and mediate the spontaneous development of intestinal inflammation. Interestingly, CYLD targets a ubiquitin-dependent kinase, transforming growth factor-beta-activated kinase 1 (Tak1), and inhibits its ubiquitination and autoactivation. Cyld-deficient T cells exhibit constitutively active Tak1 and its downstream kinases c-Jun N-terminal kinase and IkappaB kinase beta. These results emphasize a critical role for CYLD in preventing spontaneous activation of the Tak1 axis of T cell signaling and, thereby, maintaining normal T cell function.
DOI: 10.1084/jem.20062694
Institution: Pennsylvania State University
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: bronze
Awards: G1012634304, Molecular mechanisms regulating TLR signaling and inflammation, Regulation of T-cell function and autoimmune inflammation by deubiquitinases., G2922216907, Pathways of Antigen Presentation to CD8 T Cells In Vivo, Pathways of Antigen Presentation to CD8 T Cells In Vivo, EXTRAMURAL RESEARCH FACILITIES CONSTRUCTION, Viruses and Cancer, Regulation of T-cell function and autoimmune inflammation by deubiquitinase CYLD, G512942452, G6465498242, Molecular Mechanisms Mediating NF-kB2/p100 Processing, G9000040331
OpenAlex ID: W2113045740
